Asbestos exposure and asbestos-related pleural and parenchymal disease. Associations with immune imbalance
- PMID: 1826194
- DOI: 10.1164/ajrccm/143.4_Pt_1.822
Asbestos exposure and asbestos-related pleural and parenchymal disease. Associations with immune imbalance
Abstract
The study hypothesis was that asbestos exposure and asbestos-related pleural plaques and interstitial disease are associated with (1) immune imbalances favoring helper-inducer T-cell subsets in blood and bronchoalveolar lavage (BAL) and (2) T-lymphocyte accumulation in BAL. One hundred twenty-two asbestos-exposed subsets (AES), including 27 nonsmokers (NS), were evaluated and compared with 10 unexposed normal subjects. Data were collected on medical, smoking, and occupational histories, physical examination, spirometry, lung volumes, single-breath DLCO, chest films read by a "B" reader, and T-lymphocyte characterization in blood and BAL using flow cytometry analysis of monoclonal-antibody-treated cells. On average, AES were 47 yr of age and had 23 yr of asbestos exposure. Fifty-eight (48%) had pleural thickening, and seven (6%) had profusion greater than or equal to 1/0. In blood, asbestos-exposed NS had lower total and percent CD8 and lower total CD3 than did normal subjects. In BAL, asbestos-exposed NS had higher total CD3 than did normal subjects. Among AES, increased asbestos exposure was associated with increased percent CD8 in BAL and decreases in both percent lymphocytes and total CD8 in blood. Increase in CD4/CD8 ratio in BAL were associated with pleural thickening. In those seven with profusion greater than or equal to 1/0, there was increased percent CD4 in blood and decreased percent CD8 in BAL. These results suggest immune imbalance favoring helper-inducer T-cell subsets in association with asbestos exposure systemically and with pleural plaques in BAL.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Influence of cigarette smoking on bronchoalveolar lavage cellularity in asbestos-induced lung disease.Am Rev Respir Dis. 1992 Feb;145(2 Pt 1):400-5. doi: 10.1164/ajrccm/145.2_Pt_1.400. Am Rev Respir Dis. 1992. PMID: 1736749
-
[Use of flow cytometry in evaluation of cellular changes in interstitial lung diseases].Folia Med Cracov. 1997;38(3-4):69-115. Folia Med Cracov. 1997. PMID: 10481384 Clinical Trial. Polish.
-
Bronchoalveolar lavage cell and lymphocyte phenotype profiles in healthy asbestos-exposed shipyard workers.Am Rev Respir Dis. 1989 Jan;139(1):33-8. doi: 10.1164/ajrccm/139.1.33. Am Rev Respir Dis. 1989. PMID: 2912354
-
Low-dose computed tomography screening for lung cancer in people with workplace exposure to asbestos.Lung Cancer. 2019 May;131:23-30. doi: 10.1016/j.lungcan.2019.03.003. Epub 2019 Mar 6. Lung Cancer. 2019. PMID: 31027694 Review.
-
Asbestos-related pleural plaques and lung cancer.Chest. 1993 Jun;103(6):1854-9. doi: 10.1378/chest.103.6.1854. Chest. 1993. PMID: 8404113 Review.
Cited by
-
Selected new developments in asbestos immunotoxicity.Environ Health Perspect. 1998 Feb;106 Suppl 1(Suppl 1):159-69. doi: 10.1289/ehp.98106s1159. Environ Health Perspect. 1998. PMID: 9539011 Free PMC article. Review.
-
Flow cytometry in the exploration of the physiopathology of occupational lung disease.Occup Environ Med. 1999 Nov;56(11):742-6. doi: 10.1136/oem.56.11.742. Occup Environ Med. 1999. PMID: 10658559 Free PMC article.
-
Asbestos: mining exposure, health effects and policy implications.Mcgill J Med. 2007 Jul;10(2):121-6. Mcgill J Med. 2007. PMID: 18523609 Free PMC article.
-
Genome-wide Gene-Asbestos Exposure Interaction Association Study Identifies a Common Susceptibility Variant on 22q13.31 Associated with Lung Cancer Risk.Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1564-73. doi: 10.1158/1055-9965.EPI-15-0021. Epub 2015 Jul 21. Cancer Epidemiol Biomarkers Prev. 2015. PMID: 26199339 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous